Cerebrolysin 215.2mg/mL 10mL Injection

Cerebrolysin is a peptide-based injectable treatment used as an adjunct in selected neurological rehabilitation programmes. Evidence for improvement depends on the condition and outcome being measured. It does not replace emergency stroke treatment or rehabilitation.
May support selected rehabilitation goals; improvement and suitability require individual assessment and should not be guaranteed.
No. Suspected stroke needs immediate emergency evaluation and time-sensitive stroke treatment.
Do not assume so; the manufacturer's guidance limits undiluted intramuscular administration to smaller volumes.
No treatment response can be guaranteed; recovery depends on the diagnosis, injury and rehabilitation programme.
No. Functional rehabilitation remains an essential part of recovery.
Yes. Seizure history must be reviewed before use.
No. Recovery is assessed through changes in movement, communication, cognition and daily functioning over time, alongside the rehabilitation programme.
Severe renal impairment is a contraindication in the manufacturer's monograph.
Use defined neurological or functional goals and follow-up rather than subjective promises of brain repair.
Neurotrophic: related to nerve-cell support. Rehabilitation: treatment to restore function after illness or injury. Adjunct: an addition to primary treatment., AR: Cerebrolysin /mL حقن, FR: Cerebrolysin /mL, PT: Cerebrolysin /mL injeção, ES: Cerebrolysin /mL inyección, RU: Cerebrolysin /mL инъекция, ID: Cerebrolysin /mL injeksi, VI: Cerebrolysin /mL thuốc tiêm, MS: Cerebrolysin /mL suntikan, TL: Cerebrolysin /mL iniksyon, ZH-SG: Cerebrolysin /mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Cerebrolysin 215.2mg/mL 10mL Injection under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Cerebrolysin 215.2mg/mL 10mL Injection